Aetram Research India: NIFTY PHARMA Weekly Sector Outlook
Nifty Pharma Sustains Positive Bias; Move Above 26,900 May Strengthen Upside Momentum While Below 26,300 May Trigger Caution - 19.09.2026
Current Market Price: 26710.10
Market Prediction:
- Nifty Pharma is holding a positive structure after a steady upward move, with price sustaining above major moving average clusters. RSI near 63 indicates healthy momentum, while MACD reflects improving positive strength. The index is consolidating near higher levels, requiring sustained strength above 26,900 for continuation. Weakness below 26,300 may trigger corrective pressure.
Upcoming Events:
- Pharmaceutical sector earnings updates may influence investor sentiment.
- Regulatory approvals and global healthcare developments may impact stocks.
- Currency movements may affect export-oriented pharmaceutical companies.
Major Support and Resistance:
- Support: 26300, 26000, 25650
- Resistance: 26900, 27200, 27500
Volume Analysis:
- Volume participation has remained supportive during the recent uptrend, indicating continued market interest near higher levels. However, volume expansion is required above resistance zones for further momentum confirmation. Current activity reflects accumulation with moderate caution near resistance.
Final Take Away:
- Nifty Pharma continues to maintain a stronger structure compared with broader sectors, supported by positive momentum indicators. Holding 26,300 keeps the bullish setup active, while movement above 26,900 may strengthen the recovery path toward higher resistance zones.
Next Week Prediction:
- Nifty Pharma may continue with positive consolidation, with further directional movement depending on key resistance and support levels.
Scenario-Based Outlook:
- Bullish Scenario: Above 26900, price may move toward 27200–27500 zone
- Bearish Scenario: Below 26300, downside risk toward 26000–25650 zone
- Neutral Scenario: Between 26300–26900, consolidation likely
Disclaimer: This research report is for informational purposes only. This is not an offer to buy or sell securities. Past performance is not indicative of future results. There is no guarantee of returns. Investments in securities are subject to market risks including loss of capital. Investors should consult their financial advisor before making any investment decisions.
